+321 123 4567
info@test.com
My Account
  1. Home
  2. /
  3. Availability
  4. /
  5. Modelling the health and economic impacts of M72/AS01E vaccination and BCG-revaccination: estimates for South Africa

Modelling the health and economic impacts of M72/AS01E vaccination and BCG-revaccination: estimates for South Africa

Description

we used a mathematical model to estimate the health impact and cost-effectiveness of M72/AS01E and BCG-revaccination in South Africa under a range of vaccine characteristics and delivery assumptions
WHO goals and milestones
Availability, Economic impact/cost-effectivenss, Epidemiological impact

Project details

Country
South Africa
Timeline
Target group
adolescents, General Adults
Vaccine
BCG revax, M72/AS01e
Type of protection of vaccine
Prevention of disease, Prevention of infection
Type of research
Modelling
Partners involved
BMGF; LSHTM; Boston University; Harvard University; KNCV; University of Cape Town
Type of project

Resources

Contact

Joeri Buis

KNCV Team

Contact me for more information about this research

Click to copy link of this header Menu

Add A Knowledge Base Question !

You will receive an email when your question will be answered.

+ = Verify Human or Spambot ?